Open AccessGlycemic management after antenatal corticosteroid therapy
Author(s) -
Sanjay Kalra,
Bharti Kalra,
Yashdeep Gupta
Publication year - 2014
Publication title -
north american journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2250-1541
pISSN - 1947-2714
DOI - 10.4103/1947-2714.127744
Subject(s) - medicine , betamethasone , glycemic , gestational diabetes , diabetes mellitus , pregnancy , dexamethasone , intensive care medicine , obstetrics , pediatrics , gestation , endocrinology , biology , genetics
Antenatal corticosteroids (ACS) are recommended for use in antenatal mothers at risk of preterm delivery before 34 weeks. One common side-effect of these drugs is their propensity to cause hyperglycemia. A PubMed search was made using terms 'steroid,' 'dexamethasone,' 'betamethasone' with diabetes/glucose. Relevant articles were extracted. In addition, important cross-reference articles were reviewed. This review, based upon this literature search, discusses the available evidence on effects on glycemic status as well as management strategies in women with pre-existing diabetes, gestational diabetes mellitus, as well as normoglycemic women after ACS use in pregnancy.